An Observational Study on Epithelioid Sarcoma
ConditionEpithelioid Sarcoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorItalian Sarcoma Group
About this trial
Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Histological diagnosis of epithelioid sarcoma according to 2014 World Health Organization (WHO) classification, performed on biopsy or surgical specimen
Signed informed consent
Adequate patient compliance to treatment or follow up
No age limit
Disqualifiers
Other malignancies within past 5 years, with exception of carcinoma in situ of the cervix and basocellular skin cancers treated with eradicating intent
Impossibility to ensure adequate compliance
Trial population
Patient affected by epithelioid sarcoma according to 2014 WHO classification
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Treatment for Epitheloid Sarcoma
Other interventionTreatment Epitheloid Sarcoma according the disease guideline
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Epitheloid Sarcoma patients1 intervention
Trial outcomes
Primary outcomes
1
Type of treatment given to patients with ES
Number of chemotherapy treatment received patients affected by ES
Time frame
From diagnosis until the date of death from any cause assessed up to 60 monthsSecondary outcomes
1
Radiotherapy treatments
Number of patients affected by localized ES who received radiotherapy
Time frame
From the time of diagnosis and then every 6 months up to 60 months2
Chemotherapy treatments
Number of patients affected by localized ES who received chemotherapy
Time frame
From the time of diagnosis and then every 6 months up to 60 months3
Predictive biomarkers for response
Tumor biomarkers expression in tumor tissue of patients affected by ES
Time frame
At time of diagnosis and at the time of any progression where a biopsy is performed up to 60 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov